Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT

被引：5
|
作者：
Lu, Yang [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Diagnost Imaging, Dept Nucl Med, 1400 Pressler Unit 1483, Houston, TX 77030 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 11期
关键词：
multiple myeloma; lung cancer; neuroendocrine tumor; carcinoid; PET; CT; FDG; DOTATATE; NEUROENDOCRINE TUMORS; MANAGEMENT; DIAGNOSIS;
D O I：
10.1097/RLU.0000000000002706
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 69-year-old man with recurrent multiple myeloma underwent FDG PET/CT evaluation. A pulmonary nodule without higher-than-background FDG avidity was later biopsied as a low-grade neuroendocrine tumor. On further Ga-68-DOTATATE PET/CT evaluation of patient's neuroendocrine tumor, the lytic myeloma lesions revealed only mild DOTATATE avidity while the primary pulmonary neuroendocrine tumor showed intense DOTATATE uptake. The distinct imaging characteristics of different primary malignancies correlated with their underlying different pathology.
引用
收藏
页码：914 / 915
页数：2
相关论文
共 50 条
  • [41] Neuroendocrine Tumor Recurrence: Diagnosis with 68Ga-DOTATATE PET/CT
    Haug, Alexander R.
    Cindea-Drimus, Ramona
    Auernhammer, Christoph J.
    Reincke, Martin
    Beuschlein, Felix
    Waengler, Bjoern
    Uebleis, Christopher
    Schmidt, Gerwin P.
    Spitzweg, Christine
    Bartenstein, Peter
    Hacker, Marcus
    RADIOLOGY, 2014, 270 (02) : 517 - 525
  • [42] Radioiodine Uptake in Incidentally Detected Neuroendocrine Tumor Correlative Imaging With FDG PET/CT and 68Ga-DOTATATE PET/CT
    Hod, Nir
    Lantsberg, Sophie
    Levin, Daniel
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (10) : E643 - E646
  • [43] Primary Pulmonary MALT Lymphoma on 18F-FDG and 68Ga-FAPI PET/CT
    Wang, Rongxi
    Chen, Jingci
    Wang, Jiarou
    Zhu, Zhaohui
    Zhang, Jingjing
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (06) : e372 - e373
  • [44] Targeting post-infarct inflammation by PET imaging: comparison of 68Ga-citrate and 68Ga-DOTATATE with 18F-FDG in a mouse model
    Thackeray, James T.
    Bankstahl, Jens P.
    Wang, Yong
    Korf-Klingebiel, Mortimer
    Walte, Almut
    Wittneben, Alexander
    Wollert, Kai C.
    Bengel, Frank M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 317 - 327
  • [45] 18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma
    Papadakis, Georgios Z.
    Millo, Corina
    Jassel, Inderbir S.
    Bagci, Ulas
    Sadowski, Samira M.
    Karantanas, Apostolos H.
    Patronas, Nicholas J.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 189 - 190
  • [46] Prognostic value of 18F-FDG PET/CT in patients with relapsed multiple myeloma
    Guo, Yue-Hong
    Liu, Ai-Jun
    Huang, Jing-Wei
    Wang, Li
    Yang, Min-Fu
    ANNALS OF HEMATOLOGY, 2024, 103 (10) : 4145 - 4153
  • [47] Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors
    Komek, Halil
    Can, Canan
    Urakci, Zuhat
    Kepenek, Ferat
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (05) : 517 - 524
  • [48] Characteristics of Integrated 18F-FDG PET/CT in Pulmonary Cryptococcosis
    Huang, Chung-Jen
    You, Dong-Ling
    Lee, Pei-Ing
    Hsu, Li-Han
    Liu, Chia-Chuan
    Shih, Chih-Shiun
    Shih, Chiang-Ching
    Tseng, Hsiu-Chin
    ACTA RADIOLOGICA, 2009, 50 (04) : 374 - 378
  • [49] 68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer
    Walker, Ronald
    Deppen, Stephen
    Smith, Gary
    Shi, Chanjuan
    Lehman, Jonathan
    Clanton, Jeff
    Moore, Brandon
    Burns, Rena
    Grogan, Eric L.
    Massion, Pierre P.
    PLOS ONE, 2017, 12 (02):
  • [50] Identification of Wandering Masses and Tumor Heterogeneity on 68Ga-DOTATATE and 18F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT
    Baberwal, Parth
    Parghane, Rahul
    Basu, Sandip
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2024, 52 (03) : 272 - 273
12345